Nose Bleeds



Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)


Condition:   Hemorrhagic Hereditary Telangiectasia (HHT)
Interventions:   Drug: Protopic® (Tacrolimus) 0.1% ointment;   Drug: Placebo
Sponsor:   Hospices Civils de Lyon
Recruiting


Carotid Intima Media Thickness (CIMT) in Epistaxis


Conditions:   Epistaxis;   Atherosclerosis
Intervention:   Diagnostic Test: Ultrasound
Sponsor:   University of Zurich
Completed


Nasotracheal Intubation Over a Bougie


Conditions:   Nasotracheal Intubation;   Nasal Bleeding
Interventions:   Procedure: Nasotracheal intubation over a bougie;   Procedure: Conventional Nasotracheal Intubation
Sponsor:   University of Iowa
Completed


Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department


Condition:   Epistaxis
Interventions:   Drug: Tranexamic Acid;   Drug: 0.9% Sodium Chloride
Sponsor:   University of California, Davis
Recruiting


Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children


Condition:   Lacrimal Duct Obstruction
Intervention:   Procedure: "pushed" mono-canaliculonasal intubation
Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
Recruiting


Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)


Conditions:   Hereditary Hemorrhagic Telangiectasia (HHT);   Epistaxis
Interventions:   Drug: Floseal;   Other: Packing
Sponsors:   St. Michael's Hospital, Toronto;   The Ottawa Hospital
Recruiting


Management of Persistent Epistaxis Using Floseal Hemostatic Matrix


Condition:   Epistaxis
Interventions:   Device: Floseal Hemostatic Matrix;   Procedure: Traditional Nasal Packing
Sponsor:   University of Alberta
Recruiting


Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)


Condition:   Hemorrhagic Hereditary Telangiectasia (HHT)
Interventions:   Drug: Timolol nasal spray;   Drug: Placebo nasal spray
Sponsor:   Hospices Civils de Lyon
Active, not recruiting


Microporous Polysaccharide Hemospheres Epistaxis


Condition:   Epistaxis
Interventions:   Device: Microporous Polysaccharide Hemospheres;   Device: Nasal Tampon
Sponsor:   Emory University
Withdrawn


Intranasal Bevacizumab for HHT-Related Epistaxis


Conditions:   HHT;   Hereditary Hemorrhagic Telangiectasia;   Epistaxis;   Nose Bleeds;   Nasal Bleeding
Interventions:   Drug: Bevacizumab;   Drug: Placebo (Saline)
Sponsor:   Stanford University
Recruiting


Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia


Conditions:   Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Intervention:   Drug: Thalidomide
Sponsor:   IRCCS Policlinico S. Matteo
Completed


Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia


Conditions:   Epistaxis;   Hereditary Hemorrhagic Telangiectasia
Intervention:   Drug: Sodium tetradecyl sulfate (sotradecol)
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   American Rhinologic Society
Completed

Refine Your Search Advanced Search